Clinical research in primary stroke prevention: needs, opportunities, and challenges.

Neuroepidemiology 2005 13;25(2):91-104. Epub 2005 Jun 13.

National Institute of Neurological Disorders and Stroke, National Institutes of Health, 6001 Executive Boulevard, Bethesda, MD 20892, USA.

Most ( approximately 70%) of strokes are first-ever strokes, and hence to substantially reduce the neurological burden, primary prevention is crucial. Here, highlights of the National Institute of Neurological Disorders and Stroke workshop "Stroke Risk Assessment and Future Stroke Primary Prevention Trials" held January 12-13, 2004 are summarized. The Workshop discussions focused on stroke risk assessment; the high-risk vs. population-based approaches to primary prevention; desirable characteristics of candidate treatments and potential novel treatments, such as the 'polypill'; subclinical disease as risk assessment tool and as surrogate outcome, and methodological issues in stroke primary prevention trials. The importance of assessing cognitive decline as an important consequence of covert and overt vascular injury of the brain was emphasized. The scientific or logistic barriers to stroke primary prevention trials are challenging, but are not insurmountable.

Download full-text PDF

Source
http://dx.doi.org/10.1159/000086342DOI Listing
August 2005
4 Reads

Publication Analysis

Top Keywords

primary prevention
20
risk assessment
12
stroke primary
12
prevention trials
8
stroke
6
prevention
6
primary
5
workshop discussions
4
covert overt
4
summarized workshop
4
2004 summarized
4
discussions focused
4
focused stroke
4
assessment high-risk
4
consequence covert
4
stroke risk
4
12-13 2004
4
overt vascular
4
methodological issues
4
injury brain
4

References

(Supplied by CrossRef)

Similar Publications